Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed …
Posted by rtrafaelmd on 23 Apr 2009 at 07:45 am | Tagged as: Cervical Cancer
Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer : Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting … San Diego based medical device company, announced ..
See more here:
Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed …
